Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Gabelli Ggt Stock Good For Short Term Price At 4.09 Up 0.99 20260404 Is Credo Crdo Stock Overvalued Relative To Peers Price At 109.56 Up 2.59 20260408 Is Nbt Bancorp Nbtb Stock A Buy Now Price At 44.84 Down 0.70 20260413 Can Quidelortho Corporation Qdel Stock Beat Estimates Price At 14.18 Up 2.38 20260413 Centessa CNTA Stock Investment Risks Quiet 20260427 Equinix Inc EQIX Q1 2026 Earnings Top Expectations on AI Infrastructure Demand FullYear Guidance Lifted Target Corporation TGT Bullish 10Year Outlook Signals Potential 500 Upside by 2036 MLAC Mountain leadership unveils longterm strategic roadmap alongside newly released quarterly earnings report SpaceX OpenAI and Anthropic May Surpass Berkshire Hathaways Market Value on Debut Polymarket Suggests TCS and Mistral AI Forge Partnership to Offer Custom Enterprise AI Models AMDs 10 Billion Catalyst Analyzing the Market Opportunity Wes Streeting Proposes Capital Gains Tax Reforms as Part of Labour Leadership Pitch Trump Signals No Rush on Iran Nuclear Deal Naval Blockade to Continue US Productivity Growth Decelerates in Q4 as Labor Costs Rise Mirion Technologies MIR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises WeRide Inc WRD Q1 2026 Earnings EPS Misses Estimates as Revenue Disappears SPNT Q1 2026 Earnings Earnings Surpass Estimates by 178 Despite Slight Stock Decline SO Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher Matson Inc MATX Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions MVB Financial Corp Q1 2026 Earnings Earnings Beat Expectations Amidst Modest Revenue Headwinds Acumen Pharmaceuticals ABOS Slides 359 Testing NearTerm Support Public Storage PSA Holds Steady Near 305 as Traders Eye Key Resistance Levels NeuroOne Medical Technologies NMTC Drops 538 as Stock Approaches Key Support Matinas Biopharma MTNB Rises 518 as Biotech Sector Gains Momentum Kezar Life Sciences KZR Holds Steady at 729 as Shares Bounce Between Key Levels